| 1 |
30810914 | Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects. | 2019 May |
4 |
| 2 |
30895461 | Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects. | 2019 May |
1 |
| 3 |
26864332 | In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans. | 2016 Oct |
3 |
| 4 |
27191770 | Induced next-day somnolence in an elderly patient taking suvorexant concomitantly with diltiazem. | 2016 Aug |
3 |
| 5 |
26648692 | Profile of suvorexant in the management of insomnia. | 2015 |
2 |